TBX5
protein-codingT-box transcription factor 5, the group of T-box transcription factors
Gene summary
This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene is closely linked to related family member T-box 3 (ulnar mammary syndrome) on human chromosome 12. The encoded protein may play a role in heart development and specification of limb identity. Mutations in this gene have been associated with Holt-Oram syndrome, a developmental disorder affecting the heart and upper limbs. Several transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
- HOS
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~54.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0007732
Submitter: ClinGen
The T-box 5 (TBX5) gene is located on chromosome 12 at 12q24.21 and encodes a transcriptional regulator that is involved in cardiac development and limb pattern formation Mutations in TBX5 were first reported in relation to autosomal dominant Holt-Oram syndrome (HOS), a developmental disorder affecting the heart and upper limb, in 1997 (Basson et al., 1997, PMID: 8988165; Li et al., 1997, PMID: 8988164). At least 120 unique variants (missense, nonsense, frameshift, small deletions) have been reported in humans, the majority which are de novo. The upper-limb malformations associated with HOS are fully penetrant, whereas the congenital heart malformations associated with the disease may be less so. In some cases, the cardiac phenotype may be recognized prior to limb anomalies, as some upper limb malformations have a very mild presentation. In patients with mild upper limb anomalies, conduction defects may present well into adulthood with reverse phenotyping prompting skeletal assessment (PMID 29755943). Cardiac conduction defects that are associated with HOS may occur in the presence or absence of structural heart defects. While septal defects are the most common structural disease association, cardiac phenotypes including dilated and non-compaction cardiomyopathies, and complex congenital heart diseases including dextrocardia, tetralogy of fallot, and double outlet right ventricle have been reported (PMIDs 3055242, 25344219, 32449309). Evidence supporting this gene-disease relationship includes case-level and experimental data.The mechanism for TBX5 is haploinsufficiency (Basson et al., 1999, PMID:10077612; Gruenauer-Kloevekorn et al., 2003, PMID 12818525; Baban et al., 2014, PMID 24664498). This gene-disease association is supported by animal models, protein interaction studies. Functional alterations were also shown in non-patient cells harbouring missense variants in TBX5 in different affected individuals. In summary, TBX5 is definitively associated with Holt-Oram syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Syndromic Disorders Gene Curation Expert Panel on the meeting date 26Jan2021 (SOP Version 8). The summary was updated by the ClinGen Hereditary Cardiovascular Disease GCEP after meeting on March 25, 2025.
Inheritance Pattern: AD
Disease ID:MONDO:0007732
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007732
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0000992
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0007732
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0007732
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0007732
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Musculoskeletal
Intervention: Cardiovascular
Rationale: While the condition may be recognizable in the majority, individuals may have cardiac conduction abnormalities even without known cardiac malformations, and surveillance (eg, with electrocardiography) may allow early detection and management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TBX5 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_181486.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | 3 | 170 | 5 | 180 |
| missense | 16 | 24 | 288 | 41 | 369 | |
| nonsense | 44 | 7 | 4 | 55 | ||
| start loss | 0 | |||||
| frameshift | 74 | 8 | 2 | 84 | ||
| splice donor/acceptor (+/-2bp) | 15 | 11 | 1 | 27 | ||
| Total | 150 | 51 | 298 | 211 | 5 | 715 |
Highest pathogenic variant AF is 0.0000065725476
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_852259.1 | 8 | MANE Select | |
| Ensembl | ENSP00000384152.3 | 8 | MANE Select | |
| RefSeq | NP_000183.2 | 8 | Standard | |
| RefSeq | NP_542448.1 | 7 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| tbx5a | Danio rerio | Structure: cardiac muscle cell Quality: dissociated from abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Heart Development
- Cardiac Progenitor Differentiation
- Gene expression (Transcription)
- Generic Transcription Pathway
- RNA Polymerase II Transcription
Biological Process
- morphogenesis of an epithelium
- bundle of His development
- atrioventricular valve morphogenesis
- endocardial cushion development
- cardiac left ventricle formation
Molecular Function
- RNA polymerase II proximal promoter sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA binding
- DNA-binding transcription factor activity
Cellular Component
- nucleus
- nucleoplasm
- cytoplasm
- protein-containing complex
- protein-DNA complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000310346
- Coding exons
- 8
- Length
- 54512
- Individuals with no LoFs
- 125556
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 2
- Defined
- 125558
- p
- 0.00000796
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.19 | 234 | 291 | 0.803 | 0.0000153 | 3423 |
| Missense (PolyPhen) | 49 | 81.032 | 0.6047 | 997 | ||
| Synonymous | -3.44 | 170 | 122 | 1.40 | 0.00000717 | 1004 |
| Loss of Function | 4.35 | 0 | 22.1 | 0.00 | 0.00000103 | 254 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: DNA-binding protein that regulates the transcription of several genes and is involved in heart development and limb pattern formation (PubMed:25725155, PubMed:25963046, PubMed:29174768, PubMed:26917986, PubMed:27035640, PubMed:8988164). Binds to the core DNA motif of NPPA promoter (PubMed:26926761). {ECO:0000269|PubMed:25725155, ECO:0000269|PubMed:25963046, ECO:0000269|PubMed:26917986, ECO:0000269|PubMed:26926761, ECO:0000269|PubMed:27035640, ECO:0000269|PubMed:29174768, ECO:0000269|PubMed:8988164}.;
- Disease
- DISEASE: Holt-Oram syndrome (HOS) [MIM:142900]: Developmental disorder affecting the heart and upper limbs. It is characterized by thumb anomaly and atrial septal defects. {ECO:0000269|PubMed:10077612, ECO:0000269|PubMed:10842287, ECO:0000269|PubMed:12818525, ECO:0000269|PubMed:15735645, ECO:0000269|PubMed:20450920, ECO:0000269|PubMed:8988164, ECO:0000269|PubMed:8988165}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in TBX5 are associated with susceptibility to heart disorders including dilated cardiomyopathy (DCM) and atrial fibrillation (AF). DCM is characterized by ventricular and impaired systolic function, resulting in heart failure and arrhythmia. Patient are at risk of premature death. AF is a common sustained cardiac rhythm disturbance. AF is characterized by disorganized atrial electrical activity and ineffective atrial contraction promoting blood stasis in the atria and reduces ventricular filling. It can result in palpitations, syncope, thromboembolic stroke, and congestive heart failure. {ECO:0000269|PubMed:25725155, ECO:0000269|PubMed:25963046, ECO:0000269|PubMed:26917986, ECO:0000269|PubMed:27035640}.;
Recessive Scores
- pRec
- 0.209
Intolerance Scores
- RVIS EVS
- -0.55
- RVIS percentile EVS
- 19.8
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.937
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |